Perú | info:eu-repo/semantics/article
dc.date.accessioned2023-09-06T20:45:08Z
dc.date.accessioned2024-04-24T13:21:30Z
dc.date.available2023-09-06T20:45:08Z
dc.date.available2024-04-24T13:21:30Z
dc.date.created2023-09-06T20:45:08Z
dc.date.issued2023
dc.identifierhttps://hdl.handle.net/20.500.12866/14064
dc.identifierhttps://doi.org/10.1016/j.metabol.2023.155510
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9231299
dc.description.abstractBackground: The prevalence of type 2 diabetes (T2D) is increasing worldwide, due to its necessary early detection of undiagnosed DT2 patients, and to identify individuals at risk for developing T2D by a practical risk-scoring questionnaire using tools that permit early detection, especially who have more risk, one of that tool is FINDRISC. Objective: To describe the main risk factors for developing T2D at the Central Air Force Hospital in Military populations in Lima-Perú using the Finnish Diabetes Risk Score (FINDRISC). Methods: This is an observational, transversal and descriptive study, of military personnel who come to annual evaluation, all subjects (age ≥18 years) without known diabetes, were included. Individuals with more than≥ 13 points in the FINDRISC score were selected to perform an Oral Glucose Tolerance (OGTT), as a proof of gold standard for diagnoses T2D. Results: Out of 615 participants that were suitable for the study, 113 subjects with the FINDRISC ≥13 scores or higher were further examined with an OGTT, the percentage of screen-detected T2D was 27%, the prevalence of isolated IGF was 44%, isolated IGT 5% and IFG and IGT combined were 17%. Conclusion: The Findrisc score is a useful instrument of complement to the Oral Glucose Tolerance Test in the diagnosis of type 2 diabetes in high-risk patients.
dc.languageeng
dc.publisherElsevier
dc.relationMetabolism-Clinical and Experimental
dc.relation1532-8600
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectDiabetes mellitus
dc.subjectprevention
dc.subjectImpaired Fasting Glucose
dc.subjectImpaired Glucose tolerance
dc.subjectCarbohydrate intolerance
dc.subjectFINDRISC
dc.titleFeasibility Findrisc Score as a Complement to the Oral Glucose Tolerance Test to the Diagnostic of Type 2 Diabetes in a Military Hospital
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución